Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 déc. 2003 01h30 HE | Source: Novartis Pharma AG

Sandoz übernimmt Antibiotika-Produktionsbetrieb

Sandoz übernimmt Antibiotika-Produktionsbetrieb in Spanien Akquisition stärkt unternehmensinterne Produktion und bringt Ergänzung in der Gefriertrocknungs-Technologie Wien/Kundl, ...
09 déc. 2003 03h40 HE | Source: Novartis Pharma AG

Novartis honors scientists

Novartis honors scientists for outstanding contributions Top internal scientific award goes to chemist involved in Glivec® discovery Basel, 9 December 2003 - Novartis today honors 10...
08 déc. 2003 03h00 HE | Source: Novartis Pharma AG

New Data Show Higher Dosing of Gleevec Achieved Higher Response Rates in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML)

Early Findings Among Clinical Research Presented at American Society of Hematology (ASH) Meeting; At 12 months, 92% of evaluable CML patients taking 800 mg Gleevec achieved a CCR compared to 72%...
08 déc. 2003 03h00 HE | Source: Novartis Pharma AG

Post-tamoxifen Use Of Femara In Postmenopausal Women With Early Breast Cancer Reduced Risk Of Recurrence By Nearly Half (43%) and Significantly Improved Disease-Free Survival, According to Data Presented at Major Medical Meeting

Extended adjuvant data presented at San Antonio Breast Cancer Symposium supported by new data on quality of life with Femara vs. placebo, from same clinical trialEast Hanover, NJ, December 5, 2003 -...